NewAmsterdam Pharma Company NAMS Operating margin

Operating margin at other companies

AmgenAMGN

30%+6.5pp

Regeneron PharmaceuticalsREGN

24.7%-2.3pp

RFL

Rafael Holdings, Inc.RFL

-3,717.2%+1,952pp

Denali Therapeutics Inc.DNLI

-37,938%-37,986pp

ArvinasARVN

-283.8%-310pp

Alpha CognitionACOG

-250.1%—

FAQ

What is NewAmsterdam Pharma Company's operating margin?

NewAmsterdam Pharma Company (NAMS) reported operating margin of -3,432.2% in Q2 2026.

How has NewAmsterdam Pharma Company's operating margin changed year-over-year?

NewAmsterdam Pharma Company's operating margin decreased by 1171.4% year-over-year, from -270% to -3,432.2%.

What is the long-term trend for NewAmsterdam Pharma Company's operating margin?

Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's operating margin has grown at a 561.6% compound annual growth rate (CAGR), from -3.5% to -1,002.9%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.